Stock Analiz

SeaStar Medical Holding Corp ICU

Medical/Dental Instruments · IPO 2021 · data as of November 13, 2026

$0.84Market cap $4M
Open the interactive analysis →

SeaStar Medical Holding Corp (ICU) is a healthcare company listed in the US with a market value of about $4M. In the twelve months to September 30, 2026 it had revenue of $2M and net income of -$15M, a net margin of -678.2%.

Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (3/5); the weakest is track record (0/5).

Key numbers: a 5-year average ROIC of -88%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 29% above the current price.

About SeaStar Medical Holding

SeaStar Medical Holding is listed in the US and classified in medical/dental instruments, IPO year 2021. It was profitable in 0 of the last 5 years in our data. Its share count rose by 531% over three years (dilution for shareholders). It spends 609% of revenue on research and development.

Score: 1.2 / 5

Value1/5
Future growth3/5
Track record0/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • Price below intrinsic value (DCF, moderate assumptions)
  • Revenue growth above 10% last year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • PEG below 1.5
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year revenue growth above 8% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S2.1
P/B9.5
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield—
Shareholder yield0.0%
Intrinsic value vs. price+29%

Growth and quality

Revenue growth (1 yr)814.1%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-9688.6%
ROIC (5-yr avg.)-87.9%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 5 years

Fiscal yearTTM20252024202320222021
Revenue$2M$1M$135000$0——
Net income-$15M-$12M-$25M-$26M-$12M-$5M
Free cash flow——-$16M-$10M-$8M-$5M
EPS (diluted)$-2.74$-5.86$-6.63$-30.26$-37.00$-15.75
Net margin-678.2%-984.6%-18392.6%———
ROIC—-87.9%————

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 2 analysts is $10.00, 1093% above the current price; targets range from $8.00 to $12.00; the consensus rating is “Buy”; expected EPS is $-3.93 for the fiscal year ending December 31, 2026.

Frequently asked questions

Is SeaStar Medical Holding stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 29% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does SeaStar Medical Holding pay a dividend?

Not currently.

Is SeaStar Medical Holding a good stock to buy?

We do not give buy or sell advice. SeaStar Medical Holding scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.